The estimated Net Worth of John M. Hastings is at least $809 Thousand dollars as of 12 February 2020. Mr. Hastings owns over 5,357 units of Cardiovascular Systems stock worth over $583,460 and over the last 5 years he sold CSII stock worth over $225,583. In addition, he makes $0 as Vice President - Manufacturing and Operations at Cardiovascular Systems.
John has made over 1 trades of the Cardiovascular Systems stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 5,357 units of CSII stock worth $225,583 on 12 February 2020.
The largest trade he's ever made was selling 5,357 units of Cardiovascular Systems stock on 12 February 2020 worth over $225,583. On average, John trades about 412 units every 0 days since 2019. As of 12 February 2020 he still owns at least 29,173 units of Cardiovascular Systems stock.
You can see the complete history of Mr. Hastings stock trades at the bottom of the page.
John M. Hastings serves as Vice President - Manufacturing and Operations of the Company. He held several leadership positions at St. Jude Medical and Abbott Laboratories from June 2005 to March 2010 and July 2012 to September 2017, most recently as a Senior Site Director, Operations from March 2014 to September 2017. Mr. Hastings also served as Director of Engineering at American Medical Systems from May 2010 to July 2012.
John Hastings is 40, he's been the Vice President - Manufacturing and Operations of Cardiovascular Systems since 2017. There are 25 older and no younger executives at Cardiovascular Systems. The oldest executive at Cardiovascular Systems Inc. is Augustine Lawlor, 64, who is the Independent Director.
John's mailing address filed with the SEC is 1225 OLD HIGHWAY 8 NW, , ST. PAUL, MN, 55112.
Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, and Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.
Cardiovascular Systems executives and other stock owners filed with the SEC include: